Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial

BACKGROUND: Indobufen can reversibly inhibit platelet aggregation and showed to be effective in the treatment of ischaemic heart and peripheral vascular diseases. However, it is unclear whether indobufen is an alternative antiplatelet agent for treatment of patients with ischaemic stroke. AIM: To te...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yuesong, Meng, Xia, Chen, Weiqi, Jing, Jing, Lin, Jinxi, Jiang, Yong, Johnston, S Claiborne, Bath, Philip M, Dong, Qiang, Xu, An-Ding, Li, Hao, Wang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614137/
https://www.ncbi.nlm.nih.gov/pubmed/35393360
http://dx.doi.org/10.1136/svn-2021-001480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614137/
https://www.ncbi.nlm.nih.gov/pubmed/35393360
http://dx.doi.org/10.1136/svn-2021-001480

Ejemplares similares